Search
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
home
home
Gilead
Gilead
Page 3 of 4
Health
The First FDA-Approved Gene Therapy Can Cure a Type of Blindness—But May Cost $1 Million
By
Sy Mukherjee
December 19, 2017
Health
PHOTOS: The Incredible Advances We’ve Made in the War Against HIV on World AIDS Day
By
Sy Mukherjee
December 1, 2017
Health
Gene Therapy Is Revolutionary Science That Can Cure Blindness. Is It Worth $1 Million a Pop?
By
Sy Mukherjee
November 16, 2017
Health
The FDA Just Approved a Second Revolutionary Gene Therapy. A Third Is Probably on the Way
By
Sy Mukherjee
October 19, 2017
Health
Gilead’s Deal to Buy Kite Pharma Is a Game-Changer
By
Sy Mukherjee
August 28, 2017
Health
The FDA Just Approved the First Drug That Can Treat All Hepatitis C Strains in Just 8 Weeks
By
Sy Mukherjee
August 3, 2017
Health
Gilead Just Paid $125 Million to Nab a Big Market Advantage
By
Sy Mukherjee
February 21, 2017
Health
These 3 Ugly Patent Battles Could Rock Biopharma’s 2017
By
Sy Mukherjee
January 7, 2017
Health
Why GSK’s Experimental HIV Drug Could Be a Safer Bet—And a Headache for Gilead
By
Sy Mukherjee
December 21, 2016
Health
Merck Won a Mammoth $2.5 Billion from Gilead After Its Hepatitis C Drug Patent Suit
By
Reuters
December 16, 2016
Finance
Wells Fargo’s John Stumpf Is the Latest Victim of ‘CEO of the Year’ Curse
By
Jen Wieczner
October 14, 2016
Why the Fight Against AIDS Still Matters, in One Chart
By
Matthew Heimer
August 23, 2016
Health
Whistleblower Claims Celgene Colluded With Charities to Drive Profits
By
Sy Mukherjee
August 1, 2016
Health
The First-Ever Drug to Treat All Major Hep C Strains Just Got Approved
By
Sy Mukherjee
June 29, 2016
Health
Why Gilead May Not Have to Pay Merck $200 Million After All
By
Sy Mukherjee
June 7, 2016
Most Popular
Economy
The $38 trillion national debt is to blame for over $1 trillion in annual interest payments from here on out, CRFB says
By
Nick Lichtenberg
C-Suite
Red Lobster CEO Damola Adamolekun says the key to being a better leader is being a better person: ‘Leadership is...
By
Sydney Lake
Success
As millions of Gen Zers face unemployment, McDonald's CEO dishes out some tough love career...
By
Preston Fore